Trial Information
Inclusion Criteria:
- unresectable mass lesions with diffuse involvement of the orbit or the tumors with
infiltrative growth and indistinct borders which needed to have morphologic
verification
Exclusion Criteria:
- An anti-coagulant therapy at the time of biopsy,
- bleeding diathesis,
- suspected hypervascular lesions,
- orbital roof destruction with a tumor,
- apical location of the tumor
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
true identification of an orbital tumor with a core needle biopsy
Outcome Time Frame:
five years
Safety Issue:
Yes
Authority:
Russia: Ministry of Health of the Russian Federation
Study ID:
core biopsy of orbital tumors
NCT ID:
NCT01772355
Start Date:
October 2008
Completion Date:
June 2014
Related Keywords:
- Orbial Mass Lesion
- orbit; tumor; core biopsy